Intended for healthcare professionals

Student News

Drug firms neglect research into diseases affecting the poor

BMJ 2001; 323 doi: https://doi.org/10.1136/sbmj.0111407c (Published 01 November 2001) Cite this as: BMJ 2001;323:0111407c
  1. Lynn Eaton1
  1. 1London

Drugs companies are failing to develop new drugs for diseases that predominantly affect poor people because they are not profitable enough, says a report from the international medical aid agency Médecins Sans Frontières.

“Drugs are not developed according to public health need, …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription